Ma, V. T., Forati, A. W., Seker, M. E., Woods, M., Zarkhah, A. D., Skoda, L., Jin, W., Ong, I. M., Clark, P., Townsend, E., Birbrair, A., Zhao, S., Lang, J. M., Morris, Z. S., Albertini, M. R., Patel, A. V., Ayuso, J. M., Kozarek, K., Ozkan, O. (2026). Phase 1b/2 trial of melphalan-percutaneous hepatic perfusion (PHP) therapy and nivolumab/relatlimab in patients with metastatic melanoma and liver metastasis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps9600